Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$14.95 - $24.72 $389,103 - $643,387
-26,027 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$17.8 - $25.35 $463,280 - $659,784
26,027 New
26,027 $507,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.52B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Moon Capital Management LP Portfolio

Follow Moon Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moon Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Moon Capital Management LP with notifications on news.